Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

EVG.L (EVG) Share Price

There is currently no data for EVG.L

EVG.L (EVG) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
See more EVG.L trades

EVG.L (EVG) Share Price History

Time period:
to
Date Open High Low Close Volume
See more EVG.L price history

EVG.L (EVG) Regulatory News

Date Source Headline
25th Apr 2024 3:46 pm RNS Change of Name
22nd Apr 2024 10:11 am RNS Holding(s) in Company
11th Apr 2024 3:04 pm RNS Holding(s) in Company
9th Apr 2024 7:00 am RNS Holding(s) in Company
8th Apr 2024 4:03 pm RNS Holding(s) in Company
5th Apr 2024 3:39 pm RNS Director/PDMR Shareholding
5th Apr 2024 2:40 pm RNS Holding(s) in Company
4th Apr 2024 1:59 pm RNS Result of General Meeting
4th Apr 2024 7:00 am RNS Result of Retail Offer
19th Mar 2024 5:03 pm RNS Retail Offer
See more EVG.L regulatory news

EVG.L (EVG) Share News

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

25th Apr 2024 20:57

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

4th Apr 2024 17:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

19th Mar 2024 19:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Evgen Pharma finds evidence of SFX-01 activity in colon cancer models

27th Feb 2024 15:59

(Alliance News) - Evgen Pharma PLC on Tuesday said it found further evidence of SFX-01 activity in models of colon cancer. Read More

Evgen Pharma shares up on studies into SFX-01 product progressing well

19th Feb 2024 11:45

(Alliance News) - Evgen Pharma PLC on Monday said the studies into its SFX-01 product were progressing positively regarding its activity in Glioblastoma cells. Read More

See more EVG.L news
FTSE 100 Latest
Value8,809.74
Change53.53

Login to your account

Forgot Password?

Not Registered